deltatrials
Completed PHASE2 INTERVENTIONAL 4-arm NCT02175966

Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study) (FOURward)

Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis C (FOURward Study)

Sponsor: Bristol-Myers Squibb

Conditions Hepatitis C
Interventions DCV/ASV/BMS-791325 Peginterferon α-2a Ribavirin Sofosbuvir
Updated 9 times since 2017 Last updated: Aug 7, 2020 Started: Jul 28, 2014 Primary completion: Jan 28, 2015 Completion: Dec 17, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Hepatitis C and is currently completed. Bristol-Myers Squibb leads this study, which shows 9 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshotCompleted~Jun 2019 – ~Aug 2019 · 2 months · monthly snapshotCompleted~Aug 2019 – ~Sep 2020 · 13 months · monthly snapshotCompleted~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE2

  5. Aug 2019 — Sep 2020 [monthly]

    Completed PHASE2

▶ Show 4 earlier versions

  1. Jun 2019 — Aug 2019 [monthly]

    Completed PHASE2

  2. Jun 2018 — Jun 2019 [monthly]

    Completed PHASE2

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bristol-Myers Squibb
Data source: Bristol-Myers Squibb

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations